Jul 28, 2011 07:43AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Strong Global Growth Leads 2Q11 “Beat” Despite Continuing U.S. Malaise

Jul 25, 2011 08:38AM Needham & Company Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Inequitable Conduct Concluding Arguments; Proof-of-intent Hurdle Considerable

Apr 19, 2011 10:44AM Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded

Apr 15, 2011 08:07AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); U.S. and International Cubicin Sales Beat Expectations

Apr 14, 2011 07:54AM Needham & Company maintains a 'Hold' on Perrigo Co. (PRGO); TEVA Comes Through With Allegra OTC Approval, “In Numbers” but Should Provide Additional Fuel

Apr 12, 2011 07:35AM Needham & Company on Teva Pharma (TEVA): Weakness Unwarranted As Laquinimod Efficacy Metrics Largely In Line With Softened Expectations Headed Into AAN Meeting

Apr 5, 2011 09:10AM Needham & Company Reiterates a 'Buy' on Cubist Pharmaceuticals (CBST); Teva and Cubist Settle Cubicin Litigation

Mar 28, 2011 08:32AM Needham & Company on Teva Pharma (TEVA): Potential Near-Term Pivot Points Could Bump Up Short-Term Volatility; Underlying Fundamentals Unchanged

Feb 9, 2011 08:40AM Needham & Company maintains a 'Strong Buy' on Teva Pharma (TEVA); No Longer Plug & Play Generic Name Though Reward/Risk Remains Firmly Compelling

Dec 13, 2010 08:57AM Needham & Company Maintains a 'Strong Buy' on Teva Pharma (TEVA); Copaxone Citizen Petition Round Three Now Underway

Nov 30, 2010 01:28PM Needham & Company on Impax Labs (IPXL); Lawsuit Appears to Confirm That Generic Concerta Opportunity Remains A Real But Distant Star On Horizon

Nov 3, 2010 10:27AM Needham & Company on Teva Pharma (TEVA): If It Were Only As Easy As the Numbers; 3Q10 Results Impressive Though Shares Remain Overly

Jul 28, 2010 08:13AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Like Current Reward-to-Risk

Jun 30, 2010 07:47AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Generic Effexor XR Approval As Expected - Longer Exclusivity Shelf Life Could Boost 2011

Jun 2, 2010 10:55AM Notable Analyst Rating Changes 06/02: JOYG, JPM, MON, JBL Upgraded; CA, ARST, HI, EXC Downgraded

Jun 2, 2010 07:47AM Needham & Company Maintains a 'Strong Buy' on Teva Pharmaceutical (TEVA); Blitzkrieg Bops Bayer’s Yaz With Generic Launch

Feb 17, 2010 08:35AM Needham & Company Lifts Target on Teva (TEVA) to $63

Sep 25, 2008 07:55AM Needham & Co Initiates Coverage on Drugs - Generic